PCCA Celebrates Outstanding Contributions in Pharmacy Compounding
PCCA recently held its annual awards luncheon during the ThinkNext: International Seminar 2024, where numerous individuals were honored for their exemplary contributions to the field of pharmacy compounding. Held over three days, this event showcased the passion and dedication of compounding pharmacists and technicians who make a significant impact in patient care.
Recognizing Excellence: The Award Recipients
Among the esteemed honorees, Joseph P. Navarra, RPh, FACA, FAPC, was awarded the title of 2024 M. George Webber, PhD, Compounding Pharmacist of the Year. As the owner of Town Total Compounding Center and board chair of the Alliance for Pharmacy Compounding, Navarra exemplifies the commitment to quality and patient care associated with this award.
PCCA President Jim Smith and others presented this prestigious award, noting Navarra's unwavering dedication to advancing the pharmacy compounding profession. He actively advocates for the industry through educational events and conferences, demonstrating a commitment that not only benefits his patients but also inspires his peers.
Community Impact and Innovation
Navarra's approach to patient care includes developing innovative medication options, showcasing his commitment to providing personalized solutions. With initiatives like the custom formulation using NataTroche® aimed at aiding patients with depression, he continues to push boundaries in the field of compounding.
Honoring Excellence in Technician Roles
Another highlight of the event was the recognition of Stacy Hightower, CPhT, FAPC, as PCCA’s inaugural Compounding Technician of the Year. Hightower's extensive experience of over 30 years in both sterile and nonsterile compounding has solidified her reputation as a leader in her field. She has taken on roles that significantly advance her pharmacy’s operations while remaining dedicated to continuous learning and community engagement.
PCCA Director of Member Engagement Erin Michael presented this award, expressing admiration for Hightower’s commitment to professional growth and her innovative approach to pharmacy marketing.
A Role Model in the Community
Stacy's participation in legislative conferences and collaborative endeavors showcases her relentless pursuit of the highest standards in compounding. Her insights have been instrumental in shaping community perceptions of pharmacy compounding, positioning her as a role model for fellow technicians.
Acknowledging Advocacy and Innovation in Compounding
Another accolade during the ceremony was awarded to Jerry Beamer, RPh, co-owner of Andrews Apothecary, who received the 2024 L. David Sparks Advocacy Award. This recognition honors individuals who promote and advocate for compounding pharmacy. Beamer’s efforts illustrate the vital role pharmacists play in ensuring patient access to compounded medications and protecting such privileges by actively engaging with lawmakers.
PCCA Vice President of Public Affairs, Education, and Human Relations Lizzie Harbin emphasized Beamer’s impactful work, particularly his dedication to building relationships with key stakeholders in the legislative process.
Innovative Leaders in Compounding
Furthermore, Isha Gupta, PharmD, MBA, received the 2024 George Roentsch, RPh, New Innovator Award for demonstrating remarkable innovation within the field. Her commitment to education and engagement with the PCCA community has established her as a key figure among newer members, inspiring collaboration and creativity. Gupta’s efforts to continually seek better solutions for patients mark her distinctive approach to pharmacy.
PCCA Clinical Compounding Pharmacist Mark Gonzalez highlighted Gupta’s entrepreneurial spirit and dedication to patient care, underscoring the importance of nurturing emerging leaders within the compounding profession.
About PCCA: A Commitment to Personalized Medicine
PCCA actively supports the creation of personalized medicine through innovative compounding solutions that directly impact patient outcomes. With a strong network of over 3,000 pharmacy members across various countries, PCCA has established itself as a comprehensive resource in the field. Their dedication to quality and support for independent compounding pharmacies is evident as they celebrate over four decades of advancement in pharmacy compounding.
Frequently Asked Questions
What is the purpose of the PCCA awards?
The PCCA awards recognize excellence and leadership in the field of pharmacy compounding, honoring individuals for their innovation, advocacy, and commitment to quality patient care.
Who was recognized as the Compounding Pharmacist of the Year?
Joseph P. Navarra, RPh, FACA, FAPC, received the title '2024 M. George Webber, PhD, Compounding Pharmacist of the Year'.
What achievements led to the recognition of Stacy Hightower?
Stacy Hightower was honored for her leadership as a technician, her commitment to education, and her innovative approaches to pharmacy marketing over her extensive career.
Who received the award for advocacy in pharmacy compounding?
Jerry Beamer, RPh, was awarded the 2024 L. David Sparks Advocacy Award for his dedication to advocating for patient access to compounded medications.
What does PCCA do for compounding pharmacies?
PCCA provides high-quality products, education, and resources for independent compounding pharmacies, supporting the advance of personalized medicine and the compounding community.
